DUPIXENT was studied in 3 clinical trials with more than 2,100 adults with uncontrolled moderate-to-severe eczema (atopic dermatitis).
Nearly half of adult patients saw 75% 
Almost 4 times more adult patients taking DUPIXENT saw clear or almost clear skin as compared with those not taking DUPIXENT (37% taking DUPIXENT as compared to 9% taking placebo)
Adult patients experienced significant Expand the boxes below to see more detailed results from the 3 clinical studies with adults.
Results at 16 weeks when DUPIXENT was used alone*† compared to adult patients taking placebo
37% of adult patients had clear or almost clear skin compared to 9% taking placebo
48% of adult patients showed a 75% improvement in their skin compared to 13% taking placebo
33% of adult patients showed a 90% improvement in their skin compared to 7% taking placebo
*Results from "DUPIXENT alone" represents the average results from 2 studies
†All patients used a daily moisturizer
Results at 16 weeks when DUPIXENT was used every other week with topical corticosteroids compared to adult patients taking topical corticosteroids
39% of adult patients had clear or almost clear skin when DUPIXENT was used with topical corticosteroids compared to 12% taking placebo with topical corticosteroids
69% of adult patients showed a 75% improvement in their skin when DUPIXENT was used with topical corticosteroids compared to 23% taking placebo with topical corticosteroids
40% of adult patients showed a 90% improvement in their skin when DUPIXENT was used with topical corticosteroids compared to 11% taking placebo with topical corticosteroids
Adult patients experienced a significant itch reduction while
participating in clinical trials
38% of adult patients had significant itch reduction at 16 weeks when DUPIXENT was used alone compared to 11% taking placebo
59% of adult patients had significant itch reduction at 16 weeks when DUPIXENT was used with topical corticosteroids compared to 20% taking placebo with topical corticosteroids
Results represent the average results of 2 studies
DUPIXENT started working quickly (as early as 2 weeks) and continued to show results, with the majority of adult patients seeing significant skin improvement and itch reduction at 1 year of treatment when used with topical corticosteroids.
These results show the percentage of adult patients who experienced the following results at 1 year (52 weeks) while taking DUPIXENT once every other week while using topical corticosteroids compared to patients taking placebo and topical corticosteroids.
36% of adult patients had clear or almost clear skin when DUPIXENT was used with topical corticosteroids compared to 13% taking placebo with topical corticosteroids
65% of adult patients saw a 75% improvement in their skin when DUPIXENT was used with topical corticosteroids compared to 22% taking placebo with topical corticosteroids
51% of adult patients had significant itch reduction at 1 year when DUPIXENT was used with topical corticosteroids compared to 13% taking placebo with topical corticosteroids
The safety profile of DUPIXENT and topical corticosteroids through Week 52 (trial 3) in adults was generally consistent with the safety profile observed at Week 16.
Use this Healthgrades™ tool to easily find nearby specialists with experience in treating teens and adults with uncontrolled moderate-to-severe eczema (atopic dermatitis).
Our goal is for you to get the most out of your visit to the doctor. Download the discussion guide for tips on how to drive a productive conversation.
Doctor Discussion Guide 234 KBSign up for emails to get the latest news and information about DUPIXENT.
You'll receive the latest information in your email.
If you've been prescribed DUPIXENT, you can enroll in DUPIXENT MyWay with your doctor and get benefits like a personal Nurse Educator, supplemental injection support, and more.
